Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial Cohort
Christopher Colombo(Madigan Army Medical Center), Chengcai Liang(Sun Yat-sen University), Ryan C. Maves(Naval Medical Center San Diego), Marie‐Carmelle Elie(University of Florida), Victor F. Tapson(Cedars-Sinai Medical Center), Sarah L. George(Saint Louis University), Hannah Jang(Unity Health System), Rhonda E Colombo(Henry M. Jackson Foundation), David A Lindholm(Uniformed Services University of the Health Sciences), André C. Kalil(Nebraska Medical Center), Richard A. Mularski, Justin R. Ortiz(University of Maryland, Baltimore), Stuart H. Cohen(UC Davis Comprehensive Cancer Center), Angela R Branche(University of Rochester)
Cited by 23
Related Papers
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
|JAMA|2013|797
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
|Cochrane Database of Systematic Reviews|2017|648
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
|New England Journal of Medicine|2013|603
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
|Journal of the American College of Cardiology|2010|558
Influenza virus-related critical illness: pathophysiology and epidemiology
|Critical Care|2019|509